US FDA grants approval to Aurobindo Pharma's osteoporosis drug risedronate
The approved product has an estimated market size of $ 113 million for the twelve months ending October 2015, according to IMS
Risedronate sodium tablet, a generic version of Warner Chilcott’s Actonel, is used in the treatment of osteoporosis. The approved product has an estimated market size of $ 113 million for the twelve months ending October 2015, according to IMS.